CMEList logo

MLI Sharper Focus on Geographic Atrophy: Imaging-Based Strategies for Retina Specialists

Sharper Focus on Geographic Atrophy: Imaging-Based Strategies for Retina Specialists is an educational initiative designed to equip retina specialists, comprehensive ophthalmologists, and other members of the multidisciplinary ophthalmology care team with practical, evidence-based strategies for the diagnosis, monitoring, and management of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Despite advances in retinal imaging and the emergence of complement inhibitor therapies, GA remains underrecognized and inconsistently managed in clinical practice. Variability in the interpretation of multimodal imaging, the lack of standardized monitoring, and gaps in understanding the complement system’s role in disease progression continue to challenge coordinated, patient-centered care. Delayed referral, limited patient understanding of the disease course, and barriers to adherence with monitoring schedules can further delay timely intervention and complicate long-term management.

This activity is derived from a Live ISS at ASRS, originally held on July 17, 2026.

This activity addresses these gaps by reviewing the clinical and multimodal imaging features that distinguish early and intermediate AMD from GA, the lesion-progression patterns that signal worsening disease, and the role of complement dysregulation in GA pathogenesis. Faculty will also examine the mechanisms of action, candidate selection, and integration of complement inhibitor therapies into evidence-based care pathways for patients with GA secondary to AMD.

Through expert-led, case-based discussion, participants will strengthen their ability to interpret imaging findings with greater confidence, implement structured monitoring strategies, and deliver more coordinated, individualized care. Faculty will anchor the discussion in multimodal imaging and use animations of disease pathophysiology and treatment mechanisms, interactive Q&A, and collaborative problem-solving, closing with key takeaways and practical tips for GA monitoring. The program is delivered as a live, interactive industry-supported symposium (ISS) and is intended for retina specialists and other members of the multidisciplinary ophthalmology care team involved in the management of GA secondary to AMD in the United States.

Cost: Free

View Offer chevron_right

Key Features

This expert-led, case-based activity equips retina specialists and ophthalmology care teams with evidence-based strategies to diagnose, monitor, and manage geographic atrophy (GA) secondary to AMD. Key features include multimodal imaging interpretation, lesion progression assessment, complement inhibitor mechanisms and patient selection, structured monitoring, and interactive Q&A with practical clinical takeaways.

Topics Covered

  • Ophthalmology: Geographic Atrophy

Learning Objectives

After completing this activity, the participant should be better able to:

  • Assess clinical and multimodal imaging features that differentiate early and intermediate age-related macular degeneration (AMD) from geographic atrophy (GA)
  • Analyze the role of the complement system in GA pathogenesis and the mechanism of action of complement-targeted therapies
  • Select appropriate candidates for complement inhibitor therapy and integrate these agents into evidence-based care pathways for patients with GA secondary to AMD
  • Implement structured, evidence-based monitoring strategies to track GA progression and guide patient care

Target Audience

This activity is designed for retina specialists and other members of the interprofessional and multidisciplinary team involved in the management of geographic atrophy in the U.S.

Additional credit info

1.0 AAPA, ACCME, ANCC, COPE
In support of improving patient care, Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
Medical Learning Institute Inc (MLI) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour and 0.5 contact hour in the area of pharmacology.

PA
Medical Learning Institute Inc has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until August 15, 2027. PAs should only claim credit commensurate with the extent of their participation.

Optometrist Continuing Education
Medical Learning Institute Inc designates this asynchronous activity for a maximum of 1.0 COPE credit hour.

Support Statement
This activity is supported by educational grants from Astellas Pharma US, Inc. and Apellis, a subsidiary of Biogen.

Stay up-to-date

Receive special offers, keep up with MOC requirements and stay informed of the latest offerings in free online CME in your specialty.